{
    "physical_examinations": [
        {
            "date": "Not specified",
            "vital_signs": "Not specified",
            "relevant_findings": "No vital signs were reported for the twins after birth. Both twins had Apgar scores reflecting good health: one twin scored 8, 9, 9 and the other scored 9, 10, 10.",
            "changes_over_time": "Not specified"
        },
        {
            "date": "February 2016",
            "vital_signs": "Not specified",
            "relevant_findings": "Cord-blood samples from each twin showed detectable Fc-EDA concentrations of 62.4 and 932 ng per milliliter at 7 days post-administration, indicating transference from amniotic fluid.",
            "changes_over_time": "Not specified"
        },
        {
            "date": "Not specified",
            "vital_signs": "Not specified",
            "relevant_findings": "At 6 months of age, both twins had normal sweat-duct density and produced normal amounts of sweat when stimulated, as opposed to their untreated older brother who did not sweat.",
            "changes_over_time": "Sweat production remained in the normal range until the end of the observation after 22 months."
        },
        {
            "date": "Not specified",
            "vital_signs": "Not specified",
            "relevant_findings": "Patient 3, born in week 39 with an Apgar score of 10, had 1778 and 1822 sweat pores per square centimeter on the soles of his feet, indicating improvement in sweat gland development compared to untreated siblings.",
            "changes_over_time": "Pilocarpine-induced sweat production at 6 months was lower than in Patients 1 and 2, suggesting slower maturation of sweat-gland function."
        }
    ]
}